AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 78 filers reported holding AVEO PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 29.32 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2014 | $4,251,000 | -39.3% | 3,829,350 | 0.0% | 0.07% | -35.1% |
Q2 2014 | $7,008,000 | +22.4% | 3,829,350 | 0.0% | 0.11% | -17.4% |
Q1 2014 | $5,725,000 | -18.3% | 3,829,350 | 0.0% | 0.14% | -30.7% |
Q4 2013 | $7,008,000 | -11.2% | 3,829,350 | 0.0% | 0.20% | -11.6% |
Q3 2013 | $7,888,000 | -17.6% | 3,829,350 | 0.0% | 0.22% | -5.5% |
Q2 2013 | $9,573,000 | – | 3,829,350 | – | 0.24% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Deer VI & Co. LLC | 675,242 | $1,958,000 | 100.00% |
NEA Management Company, LLC | 16,362,694 | $47,452,000 | 2.11% |
Prosight Management, LP | 1,043,550 | $3,026,000 | 1.90% |
New Leaf Venture Partners, L.L.C. | 964,520 | $2,797,000 | 1.51% |
RA Capital Management | 5,062,759 | $14,682,000 | 1.12% |
X-Square Capital, LLC | 231,434 | $671,000 | 0.71% |
683 Capital Management, LLC | 2,500,000 | $7,250,000 | 0.64% |
Avoro Capital Advisors LLC | 3,231,893 | $9,372,000 | 0.45% |
EAM Global Investors LLC | 244,768 | $710,000 | 0.37% |
Polar Capital LLP | 7,877,429 | $22,845,000 | 0.23% |